Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00465972 · ClinicalTrials.gov registry record · Phase 4

The Treatment of Insomnia in Patients With HIV Disease

A Phase 4 study of HIV Infections and Insomnia, sponsored by Duke University.

Completed
Registry status
Phase 4
Development phase
44
Enrollment target
1
Study location

NCT00465972 is a Phase 4 study of HIV Infections and Insomnia that has completed, run by Duke University. The registered enrollment target is 44 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00465972, a Phase 4 study of HIV Infections and Insomnia, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 4
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This study is designed to evaluate the efficacy of two commonly prescribed sleep aids for use in patients who are HIV positive and suffer from insomnia.

Conditions Studied

HIV Infections Insomnia

Interventions

  • DRUG Placebo
  • DRUG Doxepin
  • DRUG Temazepam

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2007-03
Est. Completion 2010-08
Phase Phase 4

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00465972

The ClinicalTrials.gov registry entry for NCT00465972 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (90% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00465972 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00465972 about?

NCT00465972 is a clinical study titled "The Treatment of Insomnia in Patients With HIV Disease". This study is designed to evaluate the efficacy of two commonly prescribed sleep aids for use in patients who are HIV positive and suffer from insomnia.

What is the current status of trial NCT00465972?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2007-03. Estimated completion is 2010-08.

What conditions does trial NCT00465972 study?

This clinical trial studies the following conditions: HIV Infections, Insomnia.

What interventions are being tested in trial NCT00465972?

The interventions under investigation include: Placebo (DRUG), Doxepin (DRUG), Temazepam (DRUG).

Who is sponsoring clinical trial NCT00465972?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00465972 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Insomnia

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.